North America Rapid Influenza Diagnostic Test Market Outlook

north america rapid influenza diagnostic test market outlook (2018 to 2032) is characterized by rising demand, especially in the united states and canada. one of the major factors driving this market is the increasing prevalence of influenza. as per the centers for disease control and prevention, influenza (‘flu’) is a contagious respiratory illness caused by influenza viruses. it can cause mild to severe illness, and at times can lead to death. increasing awareness about the disease and its impact has been driving the demand for rapid influenza diagnostic tests in north america. the rising demand for point-of-care (poc) testing services and the increasing preference for minimally invasive procedures are expected to further boost the demand for rapid influenza diagnostic tests in the region. also, the advances in new technologies, such as genexpert, have enabled rapid, on-site molecular testing for influenza. the availability of diagnostics integrated with other available medical products, such as thermometers and stethoscopes, is also aiding the swift diagnosis and treatment of influenza in the region. furthermore, governments in the us and canada are encouraging the development and implementation of rapid influenza diagnostic tests to reduce the time and cost involved for the diagnosis and treatment of influenza. this is resulting in a greater availability of rapid, highly accurate, and affordable tests in the region. furthermore, the increasing adoption of point-of-care diagnostics by healthcare providers is expected to propel the demand for rapid influenza diagnostic tests in the region. the increasing penetration of immunoassay tests and increasing preference for rapid, molecular-based methods is also driving the demand for rapid influenza diagnostic tests in the region. moreover, major diagnostics manufacturers are introducing and integrating molecular testing with rapid influenza diagnostic tests. this is expected to drive the demand for rapid influenza diagnostic tests over the forecast period. additionally, the growing prevalence of influenza in developing countries has been fuelling the demand of rapid influenza diagnosis tests in north america. all these factors likely to drive the north america rapid influenza diagnostic test market outlook (2018 to 2032).